Removal of TSE agents from blood products

Vox Sanguinis, Supplement

Volumn 87, Issue 2, 2004, Pages

  Foster, P R ^a  

^a SCOTTISH NATIONAL BLOOD TRANSFUSION SERVICE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

PRION PROTEIN; PROTEINASE K;

ADSORPTION CHROMATOGRAPHY; AQUEOUS SOLUTION; B LYMPHOCYTE; BIOASSAY; BIOSAFETY; BLOOD; BLOOD DONOR; BLOOD TRANSFUSION; BOVINE SPONGIFORM ENCEPHALOPATHY; BRAIN HOMOGENATE; CELL SEPARATION; CENTRIFUGATION; CENTRIFUGE SUPERNATANT; CONFERENCE PAPER; CONFORMATION DEPENDENT IMMUNOASSAY; CREUTZFELDT JAKOB DISEASE; CRYOPRECIPITATION; DEGENERATIVE DISEASE; DEPTH FILTRATION; DIAGNOSTIC TEST; FILTER; FOOD CONTAMINATION; GERSTMANN STRAUSSLER SCHEINKER SYNDROME; IMMUNOASSAY; INFECTION; LEUKOCYTE FILTRATION; MEMBRANE FILTER; PARTITION CHROMATOGRAPHY; PATHOGENESIS; PRECIPITATION; PREVALENCE; PRION DISEASE; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN BINDING; PROTEIN CONFORMATION; PROTEIN PRECIPITATION; RODENT BIOASSAY; SEITZ FILTER; SEITZ FILTRATION; SEPARATION TECHNIQUE; SOLUBILITY; SUPERNATANT; VIRUS STRAIN; WESTERN BLOTTING; WHOLE BLOOD LEUKOCYTE DEPLETING FILTER;

ANIMALS; BIOLOGICAL PRODUCTS; BLOOD; BLOOD BANKS; BLOOD TRANSFUSION; BRAIN; CHROMATOGRAPHY; CREUTZFELDT-JAKOB SYNDROME; DRUG CONTAMINATION; HUMANS; LEUKOCYTES; PRION DISEASES; PRIONS; PRPSC PROTEINS;

EID: 4444277653     PISSN: 17416892     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (25)

1. Brown P, Preece M, Brandel JP, Sato T, McShane L, Zerr I, Fletcher A, Will RG, Pocchiari M, Cashman NR, d'Aignaux JH, Cervenakova L, Fradkin J, Schonberger LB, Collins SJ: Iatrogenic Creutzfeldt-Jakob disease at the millennium. Neurology 2000; 55:1075-81
2. Brown P: Transfusion medicine and spongiform encephalopathy. Transfusion 2001; 41:433-6
3. Reid J: Developments in variant CJD. House of Commons Hansard Debates, Part 4. 17th December 2003 (www.parliament. the-stationary-office.co.uk)
4. Hunter N, Foster J, Chong A, McCutcheon S, Parnham D, Eaton S, MacKenzie C, Houston F: Transmission of prion diseases by blood transfusion. J Gen Virol 2002; 83:267-71
5. Will RG: Epidemiology of Creutzfeldt-Jakob disease. Br Med Bull 1993; 49:960-70
6. Taylor DM: Resistance of transmissible spongiform encephalopathy agents to decontamination. Contrib Microbiol 2001; 7:58-67
7. Foster PR: Assessment of the potential of plasma fractionation processes to remove causative agents of transmissible spongiform encephalopathy. Transfus Med 1999; 9:3-14
8. Brown P, Rohwer RG, Dunstan BC, MacAuley C, Gajdusek DC, Drohan WN: The distribution of infectivity in blood components and plasma derivatives in experimental models of transmissible spongiform encephalopathy. Transfusion 1998; 38:810-6
9. Foster PR, Welch AG, McLean C, Griffin BD, Hardy JC, Bartley A, MacDonald S, Bailey AC: Studies on the removal of abnormal prion protein by processes used in the manufacture of human plasma products. Vox Sang 2000; 78:86-95
10. Vey M, Baron H, Weimer T, Gröner A: Purity of spiking agent affects partitioning of prions in plasma protein purification. Biologicals 2002; 30:187-96
11. Tateishi J, Kitamoto T, Mohri S, Satoh S, Sato T, Shepherd A, Macnaughton MR: Scrapie removal using Planova® virus removal filters. Biologicals 2001; 29:17-25
12. Reichl HE, Foster PR, Welch AG, Li Q, MacGregor IR, Somerville RA, Fernie K, Steele PJ, Taylor DM: Studies on the removal of a bovine spongiform encephalopathy-derived agent by processes used in the manufacture of human immunoglobulin. Vox Sang 2002; 83:137-45
13. Stenland CJ, Lee DC, Brown P, Petteway SR, Rubenstein R: Partitioning of human and sheep forms of the pathogenic prion protein during the purification of therapeutic proteins from human plasma. Transfusion 2002; 42:1497-1500
14. Brown P, Cervenáková L, McShane LM, Barber P, Rubenstein R, Drohan WN: Further studies of blood infectivity in an experimental model of transmissible spongiform encephalopathy, with an explanation of why blood components do not transmit Creutzfeldt-Jakob disease in humans. Transfusion 1999; 39:1169-78
15. Lee DC, Stenland CJ, Miller JLC, Cai K, Ford E, Gilligan KJ, Hartwell RC, Terry JC, Rubenstein R, Fournel M, Petteway SR: A direct relationship between partitioning of the pathogenic prion protein and transmissible spongiform encephalopathy infectivity during the purification of plasma proteins. Transfusion 2001; 41:449-55
16. Lee DC, Stenland CJ, Hartwell RC, Ford EK, Cai K, Miller JLC, Gilligan KJ, Rubenstein R, Fournel M, Petteway SR: Monitoring plasma processing steps with a sensitive Western blot assay for the detection of prion protein. J Virol Meth 2000; 84:77-89
17. UK Department of Health: Government Accepts Advice on Leucodepletion from Spongiform Encephalopathy Advisory Committee. Department of Health Press Release July 1998, 98/295
18. Klein MA, Frigg R, Flechsig E, Raeber AJ, Kalinke U, Bluethmann H, Bootz F, Suter M, Zmkernagel RM, Aguzzi A: A crucial role for B cells in neuroinvasive scrapie. Nature 1997; 390:687-90
19. McBride PA, Eikelenboom P, Kraal G, Fraser H, Bruce ME: PrP protein is associated with follicular dentritic cells of spleens and lymph nodes in uninfected and scrapie-infected mice. J Pathol 1992; 164:413-8
20. Prowse CV, Bailey A: Validation of prion removal by leucocyte-depleting filters: A cautionary tale. Vox Sang 2000; 79:248
21. Van Holten RW, Autenrieth SM: Evaluation of depth filtration to remove prion challenge from an immune globulin preparation. Vox Sang 2003; 85:20-4
22. Trejo SR, Hotta JA, Lebing W, Stenland CJ, Storms RE, Lee DC, Li H, Petteway S, Remington KM: Evaluation of virus and prion reduction in a new intravenous immunoglobulin manufacturing process. Vox Sang 2003; 84:176-87
23. Foster PR, Griffin BD, Bienek C, McIntosh RV, MacGregor IR, Somerville RA, Steele PJ, Reichl HE: Distribution of a bovine spongiform encephalopathy-derived agent over ion exchange chromatography used in the preparation of concentrates of fibrinogen and factor VIII. Vox Sang 2004; 86:92-99
24. Van Holten RW, Autenrieth S, Boose JA, Hsieh WT, Dolan S: Removal of prion challenge from an immune globulin preparation by use of a size-exclusion filter. Transfusion 2002; 42:999-1004
25. Cai K, Miller JLC, Stenland CJ, Gilligan KJ, Hartwell RC, Terry JC, Evans-Storms RB, Rubenstein R, Petteway SR, Lee DC: Solvent-dependent precipitation of prion protein. Biochim Biophys Acta 2002; 1597:28-35